Delivery Order SPE2DR25D1205-SPE2DR26F1GM2
- Not listed
- <p>The Defense Logistics Agency issued an $8,555.21 delivery order to Amerisourcebergen Drug Corp on April 21, 2026, for IBRANCE 125 MG capsules (21-count). The order is issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to military healthcare systems globally.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is May 12, 2026. The order carries firm fixed-price pricing with no set-aside.</p>
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on April 1, 2026, for Ibrance 125 mg tablets (7-count packaging), with a completion date of April 22, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical extending through December 2026, which serves as the...
- The Defense Logistics Agency issued a $17,119.68 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for supply of Ibrance 100 mg tablets under a firm fixed-price contract with completion by April 30, 2026. Place of performance is Conshohocken, PA. The order was issued without set-aside on a competitive basis. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and serves as a critical federal pharmaceutical distributor, particularly for military healthcare systems through...
- <p>The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for IBRANCE 125 MG capsule 21-count supply. Place of performance is Conshohocken, PA, with an ultimate completion date of March 23, 2026. The order carries firm fixed pricing and was issued with no set-aside.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for IBRANCE 75 mg capsules with a ceiling value of $8,561.41, with an ultimate completion date of May 18, 2026.</p> <p>This is a firm fixed-price delivery order placed against Amerisourcebergen's standing pharmaceutical supply contract with DLA. Place of performance is Conshohocken, PA. The order carries no set-aside.</p>
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Ibrance 125 mg capsule supply (21-count packages), with completion required by March 24, 2026. Place of performance is Conshohocken, PA. The order was priced firm fixed price and carried no set-aside. This delivery order is issued against Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency issued a $8,555.21 delivery order to AmerisourceBergen Drug Corp on March 24, 2026, for IBRANCE 125 MG capsules (21-count). The order is issued under the Defense Logistics Agency Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract extending through December 2026 that supplies pharmaceutical products and medical supplies to military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is April 14,...
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for supply of Ibrance 100 mg tablets under firm fixed price terms with an ultimate completion date of March 23, 2026. Place of performance is Conshohocken, PA. The order was issued without set-aside. Amerisourcebergen Drug Corp operates as a division of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs. The company holds a $999,999,999...
- The Defense Logistics Agency Troop Support Medical awarded a $7,484.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for IBRANCE 125 MG CAPSULE 21S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on August 7, 2023 through August 28, 2023. This delivery order was awarded under an existing indefinite-delivery/indefinite-quantity contract vehicle held by...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 31, 2026, for $8,555.21 covering Ibrance 125 mg capsule (21-count units), with an ultimate completion date of April 21, 2026. Place of performance is Conshohocken, PA. The order is issued under firm fixed-price pricing with no set-aside applied. This delivery order calls against Amerisourcebergen Drug Corp's parent IDC with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1GM2Delivery Order
The Defense Logistics Agency issued an $8,555.21 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for IBRANCE 125 MG CAPSULE 21S pharmaceutical supply. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of May 18, 2026. No set-aside was used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to federal healthcare systems. The company holds a single-award indefinite delivery contract with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 4/26/26 |